It’s long been known that the information from predictive blood screenings is hugely important in identifying and preventing the progression of disease.
The biggest blocker? An outdated healthcare system that focuses more on treatment than prevention. Simply put, the right tools to provide this service at scale–and affordably–haven’t been available to the general public.
But we’re trying to change that.